Sime Diagnostics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 33

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.36M

  • Investors
  • 7

Sime Diagnostics General Information

Description

Provider of an artificial intelligence-based healthcare platform intended to deliver decisive data-driven results in minutes. The company's platform offers accuracy as a neonatal clinical tool and its effectiveness as a biomarker discovery platform, enabling doctors to discover new disease biomarkers and curate unique datasets.

Contact Information

Website
www.simedx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 43 Manchester Street
  • London W1U 7LP
  • England, United Kingdom
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
SaaS, Artificial Intelligence & Machine Learning, TMT, Life Sciences
Corporate Office
  • 43 Manchester Street
  • London W1U 7LP
  • England, United Kingdom

Sime Diagnostics Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sime Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 15-Mar-2022 $4.36M Completed Generating Revenue
10. Later Stage VC 01-Apr-2021 Completed Generating Revenue
9. Later Stage VC 12-May-2020 Completed Generating Revenue
8. Later Stage VC 26-Feb-2019 Completed Generating Revenue
7. Grant 11-Jan-2018 Completed Generating Revenue
6. Accelerator/Incubator Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2017 Completed Generating Revenue
4. Early Stage VC 31-Dec-2016 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2016 $125K Completed Generating Revenue
2. Accelerator/Incubator $125K Completed Startup
To view Sime Diagnostics’s complete valuation and funding history, request access »

Sime Diagnostics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preferred Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 35,545 $0.000134 $2.82 $2.82 1x $2.82 1.95%
Ordinary 61,217 $0.000134 $2.3 $2.3 1x $2.3 3.36%
To view Sime Diagnostics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Sime Diagnostics Patents

  • 22

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

Sime Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4162279-A1 Methods and systems for predicting ards Pending 04-Jun-2020
US-20230223150-A1 Methods and systems for predicting ards Pending 04-Jun-2020
EP-4127712-A1 Systems and methods for predicting a risk of development of bronchopulmonary dysplasia Pending 26-Mar-2020
US-20230160818-A1 Systems and methods for predicting a risk of development of bronchopulmonary dysplasia Pending 26-Mar-2020
EP-3692376-A1 Lamellar body purification for diagnosis and treatment of a disease or disorder Inactive 06-Oct-2017 G01N33/92
To view Sime Diagnostics’s complete patent history, request access »

Sime Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sime Diagnostics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Consilience Ventures Venture Capital Minority
Oxford Technology Management Venture Capital Minority
Horizon 2020 SME Instrument Government
Grow London Accelerator/Incubator Minority
DigitalHealth.London Accelerator Accelerator/Incubator Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Sime Diagnostics FAQs

  • When was Sime Diagnostics founded?

    Sime Diagnostics was founded in 2014.

  • Where is Sime Diagnostics headquartered?

    Sime Diagnostics is headquartered in London, United Kingdom.

  • What is the size of Sime Diagnostics?

    Sime Diagnostics has 33 total employees.

  • What industry is Sime Diagnostics in?

    Sime Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Sime Diagnostics a private or public company?

    Sime Diagnostics is a Private company.

  • What is the current valuation of Sime Diagnostics?

    The current valuation of Sime Diagnostics is .

  • What is Sime Diagnostics’s current revenue?

    The current revenue for Sime Diagnostics is .

  • How much funding has Sime Diagnostics raised over time?

    Sime Diagnostics has raised $7.98M.

  • Who are Sime Diagnostics’s investors?

    Consilience Ventures, Oxford Technology Management, Horizon 2020 SME Instrument, Grow London, and DigitalHealth.London Accelerator are 5 of 7 investors who have invested in Sime Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »